MPX.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 29, 2025
Report Source: 2025 2nd Quarter Report
Mustera Property Group Ltd. Stock Analysis MPX.AX
Mustera Property Group Ltd. engages in the investment and development of properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2014-11-28. The firm provides a real estate development platform for quality residential, commercial, industrial and mixed-use projects. The company operates through two segments: property investment and property development. Its Mustera Investments business is engaged in acquiring high-yielding commercial assets, and it is focused on asset quality, stable cash flows, capital growth and a calculated exit. Its Property Funds Management provides property services including transaction sourcing, due diligence, property management, leasing, asset enhancement and realization. Its Mustera Development business sources and manages the development, refurbishment and repositioning of assets. Its Development Management business is engaged in the development of residential and mixed-use properties. The firm's projects are located in Applecross, East Perth, Midland, North Fremantle and Victoria Quarter.
Read More Mustera Property Group Ltd (MPX.AX) Chart
Key Statistics of Mustera Property Group Ltd (MPX.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.13Volume
321.37KP/E Ratio (TTM)
-52 Week Range
Market Cap
19.09MAvg. Volume
25.92KDividend Yield
1.79%Financial Metrics & Statements of Mustera Property Group Ltd (MPX.AX)
FAQ's for Mustera Property Group Ltd (MPX.AX)
- According to Musaffa’s Shariah screening methodology, Mustera Property Group Ltd (MPX.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.